Too many symbols leads to confusion, says EU regulators
This article was originally published in Clinica
Executive Summary
There are too many options for medical device manufacturers to develop their own symbols and a growing fear among regulators, including the US FDA and the European Commission, that their proliferation will result in a lack of understanding among users. That was what delegates heard at a recent meeting organised by the European medical device industry association (Eucomed) held in Brussels on October 29.